Cargando…
A multicentre, open-label, observational local study to evaluate the low-density lipoprotein cholesterol-lowering effect of ezetimibe as prescribed in daily routine practice in the South African population
OBJECTIVE: The study examined the efficacy, safety and tolerability of co-administering the cholesterol absorption inhibitor, ezetimibe 10 mg with ongoing statin therapy in hypercholesterolaemic patients. PATIENTS AND METHODS: In this multicentre, open-label, observational study, hypercholesterolaem...
Autores principales: | Raal, Frederick, Schamroth, Colin, Patel, Jai, Becker, Piet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Clinics Cardive Publishing
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975545/ https://www.ncbi.nlm.nih.gov/pubmed/17985033 |
Ejemplares similares
-
The evaluation of low-density lipoprotein cholesterol goals achieved in patients with established cardiovascular disease and/or hyperlipidaemia receiving lipid-lowering therapy: the South African Not At Goal study (SA-NAG)
por: Ramjeeth, Akash, et al.
Publicado: (2008) -
CEPHEUS SA: a South African survey on the under-treatment of hypercholesterolaemia
por: Raal, Frederick Johan, et al.
Publicado: (2011) -
Carotid intima–media thickness is a predictor of coronary artery disease in South African black patients
por: Holland, Zaiboonnisa, et al.
Publicado: (2009) -
Gender and ethnic differences in the control of hyperlipidaemia and other vascular risk factors: insights from the CEntralised Pan-South African survey on tHE Under-treatment of hypercholeSterolaemia (CEPHEUS SA) study
por: Rapeport, Naomi, et al.
Publicado: (2013) -
Management of acute coronary syndrome in South Africa: insights from the ACCESS (Acute Coronary Events – a Multinational Survey of Current Management Strategies) registry
por: Schamroth, Colin
Publicado: (2012)